FDA panel votes to pull Avastin in breast cancer, again
نویسندگان
چکیده
منابع مشابه
FDA pulls approval for avastin in breast cancer.
The FDA has revoked approval of the breast cancer indication for bevacizumab (Avastin; Genetech), saying that studies have not shown enough of a benefit to outweigh the drug's serious and potentially life-threatening side effects.
متن کاملFDA Panel report: January 1998.
T he Cardiovascular and Renal Advisory Panel of the FDA met January 27-28, 1998, to discuss (1) evaluation and use of intravenous inotropic agents in patients with heart failure; (2) liver function test abnormalities with a new AT 1 receptor blocker, tasosartan; and (3) the use of the platelet IIb/IIIa receptor blocker eptifibatide in syndromes of acute cardiac ischemia. Intravenous drugs for t...
متن کاملPANEL: Natural Language And Databases, Again
Natural Language and Databases has been a common panel topic for some years, partly because it has been an active area of work, but more importantly, because it has been widely assumed that database access is a good test environment for language research. I thought the time had come to look again at this assumption, and that it would be useful, for COLING 84, to do this. I therefore invited the...
متن کاملPlan B: Politics and values at the FDA, again.
tive that the U.S. Food and Drug Administration approved for prescription use in 1999. In 2003, a company called Barr Pharmaceuticals submitted to the FDA an application to switch Plan B from prescription to overthe-counter (OTC) status. At a joint meeting late that year, the FDA’s Nonprescription Drugs Advisory Committee and Advisory Committee for Reproductive Health Drugs recommended that the...
متن کاملFlubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells
Cancer stem-like cell (CS-like cell) is considered to be responsible for recurrence and drug resistance events in breast cancer, which makes it a potential target for novel cancer therapeutic strategy. The FDA approved flubendazole, has been widely used in the treatment of intestinal parasites. Here, we demonstrated a novel effect of flubendazole on breast CS-like cells. Flubendazole inhibited ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Biotechnology
سال: 2011
ISSN: 1087-0156,1546-1696
DOI: 10.1038/nbt0811-676c